Testing thalidomide for syringomyelia
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests whether the drug thalidomide can help people with syringomyelia (a fluid-filled cyst in the spinal cord) who cannot have standard surgery or for whom surgery didn't work. It aims to see if thalidomide can slow or improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You cannot have standard surgery (duraplasty or shunting) because it's too risky or it didn't work for you in the past year.
- Your doctor expects you to live longer than 12 months.
- Your blood tests (liver, kidney, blood counts, clotting) must be within certain limits.
- You must be able to swallow tablets.
- You are willing to sign a consent form (or have a caregiver who can).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if betaine can help people with syringomyelia who cannot have or did not benefit from standard surgery. You must be able to swallow tablets and have a life expectancy over 12 months.
This trial tests the drug thalidomide for people with symptomatic large granular lymphocytic leukemia (LGLL), a rare blood cancer. It aims to see if thalidomide can help control the disease and improve symptoms like low blood counts or an enlarged spleen.
This trial tests a combination of two drugs, low-dose cytarabine and thalidomide, for adults with Langerhans cell histiocytosis (LCH) that has not been treated before with systemic therapy. The goal is to see if this treatment is safe and effective for people with LCH in multiple body areas or multiple spots in one system.
This trial tests if daratumumab can help people with inherited cavernous malformations (clusters of abnormal blood vessels in the brain) who have had symptoms like bleeding or seizures. It aims to see if the drug is safe and might reduce future problems.
This study tests whether the drug thalidomide can help children with very early-onset inflammatory bowel disease (VEOIBD) when their symptoms are moderate to severe. It aims to see if thalidomide can calm the inflammation and improve quality of life.
This trial tests different doses of thalidomide to see if it can reduce or eliminate the need for blood transfusions in people with beta thalassemia major or intermedia.
Hear when a new Syringomyelia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.